Boothbay Fund Management’s Zosano Pharma Corporation ZSAN Stock Holding History

Boothbay Fund Management’s Portfolio ZSAN Stock Details ZSAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-2,025	Closed	-$289K	–	987
2018 Q2	$289K	Buy	2,025 +484	+31%	+$72.9K	0.03%	489
2018 Q1	$272K	Buy	+1,541	New	+$515K	0.03%	510
2017 Q4	–	Sell	-128	Closed	-$74K	–	849
2017 Q3	$74K	Hold	128	–	–	0.01%	561
2017 Q2	$127K	Hold	128	–	–	0.03%	603
2017 Q1	$171K	Buy	+128	New	+$154K	0.03%	627

Other funds holding ZSAN

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

LOAMU

Lombard Odier Asset Management (USA) New York $727M AUM 41.88% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Boothbay Fund Management's ZSAN Position: Q3 2018 in Review

Boothbay Fund Management sold out of Zosano Pharma Corporation (ZSAN) in Q3 2018, closing a stake of 2,025 shares — an estimated $289K sold.

Boothbay Fund Management first reported a position in ZSAN in Q1 2017 and held it in 5 quarters. The position peaked at $289K in Q2 2018. 23 funds tracked by Wall St. Rank hold ZSAN as of Q3 2018.

Boothbay Fund Management reported no remaining Zosano Pharma Corporation position as of Q3 2018 after selling out during the quarter.
Boothbay Fund Management sold 2,025 Zosano Pharma Corporation shares in Q3 2018, an estimated $289K.
Boothbay Fund Management first reported a position in Zosano Pharma Corporation in Q1 2017 and held it in 5 quarters.
Boothbay Fund Management's Zosano Pharma Corporation position peaked at $289K in Q2 2018.
23 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q3 2018.

Based on Boothbay Fund Management's 13F filing for Q3 2018, filed 14 Nov 2018.